Abstract

Antipsychotic Drug Development Continues Along Innovative Paths

Author(s): Peter F. Buckley

Intra-Cellular Therapies, Inc. recently announced the results of a Phase IB/II study of a putative antipsychotic, ITI-007.

• PDF